Literature DB >> 8170501

Tumor necrosis factor alpha decreases inositol phosphate formation and phosphatidylinositol-bisphosphate (PIP2) synthesis in rat cardiomyocytes.

C Reithmann1, K Werdan.   

Abstract

Treatment of neonatal rat cardiomyocytes for 72 h in the presence of tumor necrosis factor alpha (TNF alpha) (10 U/ml) lead to a decrease in basal and alpha 1-adrenoceptor-induced formation of the calcium-mobilizing second messenger inositol trisphosphate (IP3) and its metabolites, IP2 and IP1, by 35 and 26%, respectively. The synthesis of phosphatidylinositol bisphosphate (PIP2), the substrate of PI-specific phospholipase C, was decreased by 45% following the TNF alpha (10 U/ml) exposure. Time courses of TNF alpha (10 U/ml)-induced alterations in rat cardiomyocytes showed a parallel decline of basal inositol phosphate formation and PIP2 synthesis suggesting that the decrease in inositol phosphate formation was due to the reduction in PIP2 synthesis. As the TNF alpha-induced decrease of PIP2 synthesis was associated with a decreased synthesis of the phospholipid phosphatidylinositol (PI), the precursor of PIP2, by 33%, the decreased availability of PIP2 is apparently, at least in part, the result of the decreased synthesis of PI. As an apparent functional consequence of the decrease in IP3 formation following the TNF alpha exposure, the alpha 1-adrenoceptor-mediated induction of arrhythmias by 100 mumol/l noradrenaline + 10 mumol/l timolol was abolished in TNF alpha-pretreated rat cardiomyocytes. To investigate one of the possible mechanisms of the TNF alpha-induced decrease of PIP2 formation, the effect of TNF alpha pretreatment on glycerol-3-phosphate dehydrogenase (GDH), a key enzyme of lipogenesis, was studied: Exposure of the rat cardiomyocytes for 72 h to TNF alpha induced a concentration-dependent decrease in GDH activity by maximally 55%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8170501     DOI: 10.1007/bf00169834

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  32 in total

1.  The effects of interferons on the activity of alpha-glycerolphosphate dehydrogenase in benign prostatic hyperplasia cells in primary culture.

Authors:  S Hayward; S Cox; I Mitchell; R Hallowes; N Deshpande; J Towler
Journal:  J Urol       Date:  1987-09       Impact factor: 7.450

2.  Impairments in hepatocyte phosphoinositide metabolism in endotoxemia.

Authors:  E Rodriguez de Turco; J A Spitzer
Journal:  Metabolism       Date:  1987-08       Impact factor: 8.694

3.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

4.  Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscle.

Authors:  E Vicaut; X Hou; D Payen; A Bousseau; A Tedgui
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes.

Authors:  S F Steinberg; L M Kaplan; T Inouye; J F Zhang; R B Robinson
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

6.  Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release.

Authors:  T M McKenna
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

7.  Mechanisms of ex vivo aortic hypocontractility in endotoxemic rat.

Authors:  I Wakabayashi; K Hatake; K Sakamoto
Journal:  Eur J Pharmacol       Date:  1991-06-18       Impact factor: 4.432

8.  The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats.

Authors:  G A Gray; C Schott; G Julou-Schaeffer; I Fleming; J R Parratt; J C Stoclet
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

9.  In vivo and in vitro effects of endotoxin on vascular responsiveness to norepinephrine and signal transduction in the rat.

Authors:  E A Suba; T M McKenna; T J Williams
Journal:  Circ Shock       Date:  1992-02

10.  Rapid breakdown of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate in rat hepatocytes stimulated by vasopressin and other Ca2+-mobilizing hormones.

Authors:  J A Creba; C P Downes; P T Hawkins; G Brewster; R H Michell; C J Kirk
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

View more
  7 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  [Cytokines and heart diseases. Attempt at an update].

Authors:  K Werdan
Journal:  Med Klin (Munich)       Date:  1997-07-15

3.  Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

Authors:  R Prondzinsky; S Unverzagt; H Lemm; N Wegener; K Heinroth; U Buerke; M Fiedler; J Thiery; J Haerting; K Werdan; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-07-20       Impact factor: 0.840

Review 4.  Elucidating molecular mechanisms of septic cardiomyopathy--the cardiomyocyte model.

Authors:  K Werdan; U Müller-Werdan
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.842

5.  Interleukin-1beta mediates endotoxin- and tumor necrosis factor alpha-induced RGS16 protein expression in cultured cardiac myocytes.

Authors:  Monica Patten; Sabine Stübe; Bryan Thoma; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

6.  Exposure to the n-3 polyunsaturated fatty acid docosahexaenoic acid impairs alpha 1-adrenoceptor-mediated contractile responses and inositol phosphate formation in rat cardiomyocytes.

Authors:  C Reithmann; C Scheininger; T Bulgan; K Werdan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

7.  Septic cardiomyopathy - A not yet discovered cardiomyopathy?

Authors:  Ursula Muller-Werdan; Michael Buerke; Henning Ebelt; Konstantin M Heinroth; Anja Herklotz; Harald Loppnow; Martin Ruß; Frithjof Schlegel; Axel Schlitt; Hendrik B Schmidt; Gerold Söffker; Karl Werdan
Journal:  Exp Clin Cardiol       Date:  2006
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.